Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
APOPW was delisted on the 3rd of August, 2021.
2 hedge funds and large institutions have $0 invested in Cellect Biotechnology Ltd. Warrants to Purchase ADRs in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
100% less capital invested
Capital invested by funds: $2K → $0 (-$2K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$345 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | +$345 | +3,355 | +19% |
|
APOPW Hedge Fund Activity: Q3 2019 in Review
2 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) for Q3 2019, worth a combined $0 — down 100% from $2K a quarter earlier.
Fund positioning in APOPW was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $345.
- 2 institutional investors held Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $0 of Cellect Biotechnology Ltd. Warrants to Purchase ADRs stock for Q3 2019, down 100% quarter-over-quarter.
- 0 funds opened new Cellect Biotechnology Ltd. Warrants to Purchase ADRs positions in Q3 2019 and 0 closed out.
- The largest Cellect Biotechnology Ltd. Warrants to Purchase ADRs buyer in Q3 2019 was Susquehanna International Group, an estimated $345 added.
Based on aggregated 13F filings for Q3 2019.